Wardynski & Partners has advised Bio-Rad Laboratories on its acquisition of Curiosity Diagnostics from Scope Fluidics for a total consideration of up to USD 170 million in upfront and future milestone payments. Deloitte Legal advised Scope Fluidics on the sale.
According to Wardynski & Partners, “Curiosity Diagnostics, a late-stage, pre-commercial platform company, is in the process of developing a sample-to-answer, rapid diagnostics PCR system for the molecular diagnostics market. The PCR|ONE system offers an exceptionally easy procedure to perform a genetic test in disposable cartridges, in a fully automated procedure, in an exceptionally short time of 20 minutes.”
Bio-Rad develops, manufactures, and markets a range of products for the life science research and clinical diagnostic markets. Based in Hercules, California, Bio-Rad has a network of operations with approximately 7,900 employees worldwide and USD 2.9 billion in revenues in 2021.
Wardynski & Partners’ team included Partners Katarzyna Wojcik-Bakowska and Monika Gorska, Counsel Adam Pawlisz, Associate Krzysztof Drzymala, and Lawyers Katarzyna Jaroszynska and Oliwia Kruczynska.
Deloitte Legal’s team included Partner Ryszard Manteuffel, Associate Partner Robert Semczuk, Senior Managing Associate Jakub Labuz, and Associate Blazej Badera.